Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
about
Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies"Effector mechanisms of rejectionAntibody-mediated rejection: emergence of animal models to answer clinical questionsImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisAuto-antibodies to β-F1-ATPase and vimentin in malignant mesotheliomaCharacterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathyNon-MHC antigenic targets of the humoral immune response in transplantationLeft ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imagingAntiperlecan antibodies are novel accelerators of immune-mediated vascular injury.Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome.Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisGeneration of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart TransplantationMyocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus NephritisHLA and MICA: targets of antibody-mediated rejection in heart transplantation.Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1.Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile?Role of anti-vimentin antibodies in allograft rejection.Report from a consensus conference on antibody-mediated rejection in heart transplantationVimentin is a target of PKCβ phosphorylation in MCP-1-activated primary human monocytes.Report from a consensus conference on the sensitized patient awaiting heart transplantationImpact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.DNA vaccines for transplantation.Overview of pathophysiology and treatment of human lupus nephritis.The importance of non-HLA antibodies in transplantation.The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.Role of alloimmunity and autoimmunity in allograft rejection.Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.Antibodies beyond HLA.Autoimmune Reactivity in Graft Injury: Player or Bystander?Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.Exosomes Expressing the Self-Antigens Myosin and Vimentin Play an Important Role in Syngeneic Cardiac Transplant Rejection Induced by Antibodies to Cardiac Myosin.Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection.Vimentin and Anti Vimentin Antibodies in Chagas' Disease.
P2860
Q26780481-A1BEEE76-1958-4AEA-8A05-620CA68475F8Q27027082-6FB75924-915E-413D-B4EF-D1574D29BC4EQ27692014-37006646-CABA-4489-8DC4-F32725026340Q28084366-55174927-F1B8-4180-9A67-5D52E05E1410Q34056345-5072C21F-AD27-4152-8485-75118154623AQ34238488-9F89AEAC-0C47-4E08-B3A1-D79007789373Q34259047-D96D00C3-A288-4C49-A0A1-BA97735AF6A0Q34433298-7B27A256-FDDD-46D7-A566-47BC4E16375BQ34595998-04FEFB23-776E-4922-9B5E-E30AC9E488C2Q34684028-525FDED7-DD4E-442D-B148-550EBA6C6CFBQ35324023-175EB7D6-F5AC-4447-A6E6-DA4FBF1B26F3Q35954030-DEAE8053-556B-478F-BD5A-FF1243313F6DQ36085051-C6FFF555-A1A2-49B3-BFD1-310A74F5D6CDQ36299959-7B56A8EA-D5E1-450D-AA51-95411B2C680DQ36584523-B8218229-8846-4BA1-BBA8-DFD63A4BE429Q36979114-83F23FA8-11D9-48FE-B847-0F5D79F0D6B3Q37032289-75033617-3445-403B-BB44-2566D9D4E38CQ37163146-C6445343-3090-4BB9-8EFA-BE5714CB8C93Q37286553-5A9183C0-4DFA-40F1-8F0B-6C895AE972C1Q37313051-052D31EA-C44C-47AC-B81B-7940614C8E31Q37319302-AAE5CC5A-FDE8-421B-9C3D-ECB64CB2E9C7Q37414657-AC3D5576-6E3E-41AE-88F4-C3853AE49E70Q37660263-70D60B18-995D-4348-B3E1-935FF4849689Q37725897-781200CB-A11E-4AA2-89DF-2F64358D73E2Q38876110-60693E1F-39F2-429C-82C6-234A39362722Q38877375-7598061E-1E13-4013-AE45-4AD12FE5D821Q38995184-FFCEE26A-958A-43D9-985D-E07BC6CEFFFCQ39228029-C5E7D7D4-3111-4C24-B252-623041848EEAQ41226453-0BA6FB0D-359B-4CA9-9E85-4583E54B2DA4Q41849097-1A18ADAD-05DA-4B86-BB36-0C023E55E748Q43865301-6B1D4301-5CFA-4A2C-97D9-D2180CCF2047Q45763669-73EE6717-C7C0-4BB5-AEA2-398078ECD828Q46920946-CD497FA9-4C62-45ED-A975-D8B85404216CQ48055653-C58349CF-140F-4266-9095-8685BA3817BCQ50117728-A7C114A9-B033-4680-BCDC-A685D03BAE38Q51249816-0980918D-162A-47B5-A468-7626EEFD68A5Q53241382-5C7DE96A-DFDE-47D5-BB45-F5A923479489Q54256062-6F0AA671-ECE4-4B40-AEE6-2CB76FFC99C3
P2860
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
@ast
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
@en
type
label
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
@ast
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
@en
prefLabel
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
@ast
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
@en
P2093
P2860
P1476
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts
@en
P2093
Angela Holder
Ann McCormack
Balakrishnan Mahesh
Marlene L Rose
Padmini Sarathchandra
P2860
P304
P356
10.2353/AJPATH.2007.060728
P407
P50
P577
2007-04-01T00:00:00Z